1. Home
  2. NBTB vs HAE Comparison

NBTB vs HAE Comparison

Compare NBTB & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NBTB

NBT Bancorp Inc.

HOLD

Current Price

$45.43

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$60.27

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBTB
HAE
Founded
1856
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.6B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
NBTB
HAE
Price
$45.43
$60.27
Analyst Decision
Strong Buy
Buy
Analyst Count
3
9
Target Price
$52.00
$84.13
AVG Volume (30 Days)
200.9K
546.0K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
3.27%
N/A
EPS Growth
12.12
44.54
EPS
3.33
2.46
Revenue
$182,952,000.00
$910,373,000.00
Revenue This Year
$16.82
N/A
Revenue Next Year
$4.88
$5.23
P/E Ratio
$13.56
$24.55
Revenue Growth
10.40
N/A
52 Week Low
$39.14
$47.32
52 Week High
$46.92
$87.32

Technical Indicators

Market Signals
Indicator
NBTB
HAE
Relative Strength Index (RSI) 66.77 54.18
Support Level $41.68 $48.47
Resistance Level $45.97 $66.86
Average True Range (ATR) 0.81 1.82
MACD 0.41 0.58
Stochastic Oscillator 86.65 83.20

Price Performance

Historical Comparison
NBTB
HAE

About NBTB NBT Bancorp Inc.

NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: